EDITAS MEDICINE INC.
2.3800
25-November-24 15:45:01
15 minutes delayed
Stocks
-0.0600
-2.46%
Today's range
2.3450 - 2.5300
ISIN
N/A
Source
NASDAQ
-
27 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Strengthens Board of Directors with Appointment of New Chair and New Director
13 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
08 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates
22 Feb 2023 05:15:00 By Nasdaq GlobeNewswire
-
15 Feb 2023 05:45:00 By Nasdaq GlobeNewswire
-
19 Jan 2023 06:00:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Strategic Updates and Portfolio Reprioritization
09 Jan 2023 07:15:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at the 41st Annual J.P. Morgan Healthcare Conference
04 Jan 2023 05:30:00 By Nasdaq GlobeNewswire
-
06 Dec 2022 05:30:00 By Nasdaq GlobeNewswire
-
01 Dec 2022 15:01:00 By Nasdaq GlobeNewswire
-
17 Nov 2022 06:15:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Third Quarter 2022 Results and Business Updates
02 Nov 2022 05:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Third Quarter 2022 Results and Corporate Update
26 Oct 2022 05:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Participate in Upcoming Investor Conferences
01 Sep 2022 05:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2022 Results and Business Updates
03 Aug 2022 05:29:00 By Nasdaq GlobeNewswire
-
27 Jul 2022 05:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Second Quarter 2022 Results and Corporate Updates
26 Jul 2022 05:26:00 By Nasdaq GlobeNewswire
-
Editas Medicine Reports Inducement Grant to New Chief Medical Officer
20 Jul 2022 15:30:00 By Nasdaq GlobeNewswire
-
Editas Medicine Appoints Baisong Mei, M.D., Ph.D., as Chief Medical Officer
18 Jul 2022 06:00:00 By Nasdaq GlobeNewswire